Global Humanized Mouse and Rat Model Market to Reach $219.3 Million by 2030

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

| Source: ReportLinker ReportLinker

New York, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Humanized Mouse and Rat Model Industry" - https://www.reportlinker.com/p06041640/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Humanized Mouse and Rat Model Market to Reach $219.3 Million by 2030

In the changed post COVID-19 business landscape, the global market for Humanized Mouse and Rat Model estimated at US$121.4 Million in the year 2022, is projected to reach a revised size of US$219.3 Million by 2030, growing at aCAGR of 7.7% over the period 2022-2030. Humanized Mouse Models, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$205.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Humanized Rat Models segment is readjusted to a revised 6.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $33.1 Million, While China is Forecast to Grow at 11% CAGR

The Humanized Mouse and Rat Model market in the U.S. is estimated at US$33.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$47.1 Million by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.

Select Competitors (Total 44 Featured)
- Axenis S.A.S.
- Charles River Laboratories International, Inc.
- Crown Bioscience, Inc.
- Genoway S.A.
- Harbour Antibodies BV
- Hera BioLabs
- inGenious Targeting Laboratory, Inc.
- Taconic Biosciences, Inc.
- The Jackson Laboratory
- Trans Genic, Inc.


Read the full report: https://www.reportlinker.com/p06041640/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Humanized Mouse & Rat Model - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ for Years 2022 through 2030 and % CAGR

Table 2: World 8-Year Perspective for Humanized Mouse and Rat
Model by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2023 &
2030

Table 3: World Recent Past, Current & Future Analysis for
Humanized Mouse Models by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ for Years 2022 through 2030 and % CAGR

Table 4: World 8-Year Perspective for Humanized Mouse Models by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 5: World Recent Past, Current & Future Analysis for
Humanized Rat Models by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
for Years 2022 through 2030 and % CAGR

Table 6: World 8-Year Perspective for Humanized Rat Models by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Neuroscience by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 8: World 8-Year Perspective for Neuroscience by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 9: World Recent Past, Current & Future Analysis for
Hematopoesis by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 10: World 8-Year Perspective for Hematopoesis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 11: World Recent Past, Current & Future Analysis for
Oncology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 12: World 8-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Immunology & Infectious Diseases by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ for Years 2022 through 2030 and % CAGR

Table 14: World 8-Year Perspective for Immunology & Infectious
Diseases by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2023 & 2030

Table 15: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
for Years 2022 through 2030 and % CAGR

Table 16: World 8-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2023 & 2030

Table 17: World Recent Past, Current & Future Analysis for
Academic & Research Institutions by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ for Years 2022 through 2030 and % CAGR

Table 18: World 8-Year Perspective for Academic & Research
Institutions by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2023 & 2030

Table 19: World Humanized Mouse and Rat Model Market Analysis
of Annual Sales in US$ for Years 2014 through 2030

Table 20: World Recent Past, Current & Future Analysis for
Pharma & Biotech Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ for Years 2022 through 2030 and % CAGR

Table 21: World 8-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Contract Research Organizations (CROs) by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ for Years 2022 through 2030 and % CAGR

Table 23: World 8-Year Perspective for Contract Research
Organizations (CROs) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2023
(E)
Table 24: USA Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 25: USA 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 26: USA Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 27: USA 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 28: USA Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 29: USA 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

CANADA
Table 30: Canada Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 31: Canada 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 32: Canada Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 33: Canada 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 34: Canada Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 35: Canada 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

JAPAN
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 36: Japan Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 37: Japan 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 38: Japan Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 39: Japan 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 40: Japan Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 41: Japan 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

CHINA
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2023 (E)
Table 42: China Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 43: China 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 44: China Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 45: China 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 46: China Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 47: China 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

EUROPE
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 48: Europe Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 49: Europe 8-Year Perspective for Humanized Mouse and Rat
Model by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2023 & 2030

Table 50: Europe Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 51: Europe 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 52: Europe Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 53: Europe 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 54: Europe Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 55: Europe 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

FRANCE
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2023 (E)
Table 56: France Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 57: France 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 58: France Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 59: France 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 60: France Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 61: France 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

GERMANY
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 62: Germany Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 63: Germany 8-Year Perspective for Humanized Mouse and
Rat Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 64: Germany Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 65: Germany 8-Year Perspective for Humanized Mouse and
Rat Model by Application - Percentage Breakdown of Value Sales
for Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 66: Germany Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 67: Germany 8-Year Perspective for Humanized Mouse and
Rat Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

ITALY
Table 68: Italy Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 69: Italy 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 70: Italy Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 71: Italy 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 72: Italy Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 73: Italy 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

UNITED KINGDOM
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2023
(E)
Table 74: UK Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 75: UK 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 76: UK Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 77: UK 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 78: UK Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 79: UK 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

SPAIN
Table 80: Spain Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 81: Spain 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 82: Spain Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 83: Spain 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 84: Spain Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 85: Spain 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

RUSSIA
Table 86: Russia Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 87: Russia 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 88: Russia Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 89: Russia 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 90: Russia Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 91: Russia 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

REST OF EUROPE
Table 92: Rest of Europe Recent Past, Current & Future Analysis
for Humanized Mouse and Rat Model by Type - Humanized Mouse
Models and Humanized Rat Models - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 93: Rest of Europe 8-Year Perspective for Humanized Mouse
and Rat Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 94: Rest of Europe Recent Past, Current & Future Analysis
for Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 95: Rest of Europe 8-Year Perspective for Humanized Mouse
and Rat Model by Application - Percentage Breakdown of Value
Sales for Oncology, Immunology & Infectious Diseases,
Neuroscience, Hematopoesis and Other Applications for the Years
2023 & 2030

Table 96: Rest of Europe Recent Past, Current & Future Analysis
for Humanized Mouse and Rat Model by End-Use - Academic &
Research Institutions, Pharma & Biotech Companies and Contract
Research Organizations (CROs) - Independent Analysis of Annual
Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 97: Rest of Europe 8-Year Perspective for Humanized Mouse
and Rat Model by End-Use - Percentage Breakdown of Value Sales
for Academic & Research Institutions, Pharma & Biotech
Companies and Contract Research Organizations (CROs) for the
Years 2023 & 2030

ASIA-PACIFIC
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 98: Asia-Pacific Recent Past, Current & Future Analysis
for Humanized Mouse and Rat Model by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 99: Asia-Pacific 8-Year Perspective for Humanized Mouse
and Rat Model by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2023 & 2030

Table 100: Asia-Pacific Recent Past, Current & Future Analysis
for Humanized Mouse and Rat Model by Type - Humanized Mouse
Models and Humanized Rat Models - Independent Analysis of
Annual Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 101: Asia-Pacific 8-Year Perspective for Humanized Mouse
and Rat Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 102: Asia-Pacific Recent Past, Current & Future Analysis
for Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 103: Asia-Pacific 8-Year Perspective for Humanized Mouse
and Rat Model by Application - Percentage Breakdown of Value
Sales for Oncology, Immunology & Infectious Diseases,
Neuroscience, Hematopoesis and Other Applications for the Years
2023 & 2030

Table 104: Asia-Pacific Recent Past, Current & Future Analysis
for Humanized Mouse and Rat Model by End-Use - Academic &
Research Institutions, Pharma & Biotech Companies and Contract
Research Organizations (CROs) - Independent Analysis of Annual
Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 105: Asia-Pacific 8-Year Perspective for Humanized Mouse
and Rat Model by End-Use - Percentage Breakdown of Value Sales
for Academic & Research Institutions, Pharma & Biotech
Companies and Contract Research Organizations (CROs) for the
Years 2023 & 2030

AUSTRALIA
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Australia for 2023 (E)
Table 106: Australia Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 107: Australia 8-Year Perspective for Humanized Mouse and
Rat Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 108: Australia Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 109: Australia 8-Year Perspective for Humanized Mouse and
Rat Model by Application - Percentage Breakdown of Value Sales
for Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 110: Australia Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 111: Australia 8-Year Perspective for Humanized Mouse and
Rat Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

INDIA
Humanized Mouse and Rat Model Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in India for 2023 (E)
Table 112: India Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Type - Humanized Mouse Models
and Humanized Rat Models - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 113: India 8-Year Perspective for Humanized Mouse and Rat
Model by Type - Percentage Breakdown of Value Sales for
Humanized Mouse Models and Humanized Rat Models for the Years
2023 & 2030

Table 114: India Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by Application - Oncology,
Immunology & Infectious Diseases, Neuroscience, Hematopoesis
and Other Applications - Independent Analysis of Annual Sales
in US$ for the Years 2022 through 2030 and % CAGR

Table 115: India 8-Year Perspective for Humanized Mouse and Rat
Model by Application - Percentage Breakdown of Value Sales for
Oncology, Immunology & Infectious Diseases, Neuroscience,
Hematopoesis and Other Applications for the Years 2023 & 2030

Table 116: India Recent Past, Current & Future Analysis for
Humanized Mouse and Rat Model by End-Use - Academic & Research
Institutions, Pharma & Biotech Companies and Contract Research
Organizations (CROs) - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 117: India 8-Year Perspective for Humanized Mouse and Rat
Model by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutions, Pharma & Biotech Companies
and Contract Research Organizations (CROs) for the Years 2023 &
2030

SOUTH KOREA

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06041640/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

            











    

        

        
Contact Data